e-learning
resources
ERJ
2009
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Safety of long-acting β-agonists: urgent need to clear the air remains
Beasley R., Martinez F. D., Hackshaw A., Rabe K. F., Sterk P. J., Djukanovic R.
Source:
Eur Respir J 2009; 33: 3-5
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Beasley R., Martinez F. D., Hackshaw A., Rabe K. F., Sterk P. J., Djukanovic R.. Safety of long-acting β-agonists: urgent need to clear the air remains. Eur Respir J 2009; 33: 3-5
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013
Inhaler technique: An unmet need in patients with difficult asthma?
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Year: 2004
Is it feasible for respiratory physiologists to carry out inhaler device technique checks during routine pulmonary function tests?
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Long-acting β-agonists: a review of formoterol safety data from asthma clinical trials
Source: Eur Respir J 2009; 33: 21-32
Year: 2009
Lung function testing in the COVID era: safety concerns you should consider
Source: COVID-19 Videos
Year: 2020
Validation of a new inhaled therapeutic algorithm for the stable COPD patient: The COPD easy treatment project
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015
Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002
Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016
The effect of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A real practice analysis in Italy
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
Is a more frequent use of small volume nebulizer aerosol during hospitalisation by respiratory nurses a guarantee for better adherence to aerosol guidelines?
Source: Annual Congress 2010 - The nursing challenges and strategies when caring for patients with chronic lung disease
Year: 2010
“I don’t think there’s a simple way of doing it:” the use of an electronic alert to identify excessive prescribing of short-acting beta2-agonists for people with asthma – a qualitative study with asthma experts and primary care staff
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Safety profile of glycopyrronium in patients with COPD: An innovative approach to analyse data from post-marketing surveillance (PMS)
Source: International Congress 2014 – Asthma and COPD management
Year: 2014
Inhaled corticosteroids - widely prescribed in early life despite little data on safety and efficacy
Source: Eur Respir J 2001; 18: Suppl. 33, 523s
Year: 2001
Home nebulizers: outcome of 151 inhaled therapy optimization assessments using methodology recommended in ERS nebulizer guidelines
Source: Eur Respir J 2002; 20: Suppl. 38, 234s
Year: 2002
Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children
Source: Eur Respir J, 50 (6) 1700910; 10.1183/13993003.00910-2017
Year: 2017
PAH: what surgeons can offer when medication fails
Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist
Year: 2013
Protocol of early mobilization and rehabilitation in critical patients using inotropic medications: Is it really safe? Our hands on practice!
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept